Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
158.8 USD | -0.50% | -5.30% | +2.59% |
02:52pm | Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196 | MT |
02:31pm | Barclays Adjusts Price Target on AbbVie to $187 From $195 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.59% | 283B | |
+26.86% | 661B | |
+27.43% | 566B | |
-6.40% | 352B | |
+20.62% | 332B | |
+13.91% | 231B | |
+5.17% | 200B | |
-9.12% | 195B | |
-5.00% | 145B | |
-10.51% | 144B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Gets US FDA's Full Approval for Ovarian Cancer Treatment